Section 06
About the Commissioners
About the Commissioners
Established as part of the 2022 annual defense authorization bill (FY22 NDAA) the National Security Commission on Emerging Biotechnology (NSCEB) was given a clear and urgent mandate: to conduct a comprehensive review of emerging biotechnology’s impact on national security and provide practical recommendations to preserve American dominance in this field.
The NSCEB is an independent commission currently comprised of 11 commissioners appointed by a bipartisan group of Members of the House and Senate. We include four Members of Congress—two from each chamber, and two from each party—and seven prominent industry leaders, academic experts, and former government officials from the defense and intelligence communities.
Our work is short-term in nature. Our directive is to provide recommendations and support their implementation, after which point this Commission will dissolve (December 2026).
NSCEB Commissioners
Senator Todd Young
(R-IN) Chair
Dr. Michelle Rozo
Vice Chair
Senator Alex Padilla
(D-CA)
Representative Stephanie Bice
(R-OK)
Representative Ro Khanna
(D-CA)
Paul Arcangeli
Dr. Angela Belcher
Dawn Meyerriecks
Dr. Eric Schmidt
Dr. Alexander Titus
Dr. Dov Zakheim